Breaking:
China’s AI Boom: What It Means for Indian Stock Markets Anthropic Files for IPO as H1 Revenue Hits $16.3 Billion Microsoft Offers Voluntary Buyouts to 60,000 Employees Rising Crude Oil Prices Putting Pressure on India's Stock Market RBI in Forex Intervention: Does It Target Rupee Levels? India’s Defence-Tech Startups Build Indigenous Solutions
Quick Read Web Stories Games & Puzzles Search
Divine Media 24 News Worth Reading
Tuesday, October 27, 2026
AdvertisementThe Puranic
Home » Topic

Nivorz

Dr Reddy’s Launches Nivorz in India’s Biosimilar Market Health

Dr Reddy’s Launches Nivorz in India’s Biosimilar Market

Dr Reddy’s enters India’s biosimilar immuno-oncology market with Nivorz, a biosimilar of nivolumab, developed and manufactured at its Hyderabad facility.

By Divine Media 24·1 month ago
Your choice about your data

This site needs a couple of cookies to work at all, and those are always on. Beyond that, nothing loads unless you say so. You can change your mind at any time, and saying no costs you nothing on this site. Read the privacy notice for the detail.

Choose for each purpose